| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |